In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 199-209

  Chen, Bao ^a   Wang, Zhouhua ^a   Quan, Guilan ^a   Peng, Xinsheng ^a   Pan, Xin ^a   Wang, Rongchang ^a   Xu, Yuehong ^a   Li, Ge ^a   Wu, Chuanbin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bioavailability; Carbamazepine; Liquisolid; Ordered mesoporous silica; Poorly water soluble drug

Indexed keywords

ADSORBENT; CARBAMAZEPINE; CETRIMIDE; MACROGOL 400; NITROGEN; SILICON DIOXIDE; MACROGOL 4000; MESOPOROUS SILICA; UNCLASSIFIED DRUG;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DESORPTION; DOG; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; FAST RELEASE TABLET; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIQUISOLID FORMULATION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; POROSITY; SCANNING ELECTRON MICROSCOPY; SMALL ANGLE X RAY DIFFRACTION; SURFACE PROPERTY; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; WIDE ANGLE X RAY DIFFRACTION; X RAY DIFFRACTION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUISOLID CAPSULE; PLASMA CONCENTRATION-TIME CURVE; SINGLE DRUG DOSE;

ADSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; DOGS; FEMALE; PARTICLE SIZE; POROSITY; SILICON DIOXIDE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 84863065869     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S26763     Document Type: Article

References (41)

1. Karmarkar AB, Gonjari ID, Hosmani AH. Liquisolid technology for dissolution rate enhancement or sustained release. Expert Opin Drug Deliv. 2010;7:1227-1234.
2. El-Houssieny BM, Wahman LF, Arafa NM. Bioavailability and biological activity of liquisolid compact formula of repaglinide and its effect on glucose tolerance in rabbits. Biosci Trends. 2010;4:17-24.
3. Nokhodchi A, Aliakbar R, Desai S, Javadzadeh Y. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release. Colloids Surf B Biointerfaces. 2010;79:262-269.
4. Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm. 2009;73:373-384.
5. Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech. 2009;10:183-192.
6. Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008;69:993-1003.
7. Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique. Eur J Pharm Biopharm. 2008;69:342-347.
8. Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocorti-sone liquisolid tablets. J Pharm Sci. 1998;87:867-872.
9. Nokhodchi A, Hentzschel CM, Leopold CS. Drug release from liquisolid systems: speed it up, slow it down. Expert Opin Drug Deliv. 2011;8: 191-205.
10. Friedrich H, Fussnegger B, Kolter K, Bodmeier R. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur J Pharm Biopharm. 2006;62:171-177.
11. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature. 1992;359:710-712.
12. Beck JS, Vartuli JC, Roth WJ, et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J Am Chem Soc. 1992;114:10834-10843.
13. Kim JY, Yoon SB, Yu JS. Template synthesis of a new mesostructured silica from highly ordered mesoporous carbon molecular sieves. Chem Mater. 2003;15:1932-1934.
14. Zhang WM, Liu J, Sun ZX, Fan BQ, Yang ZD, Forsling W. Synthesis of mesoporous silica by a surface charge reversal route. J Colloid Interface Sci. 2010;349:473-476.
15. Chen L, Wang YM, He MY. Morphological control of mesoporous silica SBA-15 synthesized at low temperature without additives. J Porous Mater. 2011;18:211-216.
16. He QJ, Cui XZ, Cui FM, Guo LM, Shi JL. Size-controlled synthesis of monodispersed mesoporous silica nano-spheres under a neutral condition. Microporous Mesoporous Mater. 2009;117:609-616.
17. Yu SQ, Zhao RY, Liu CG, Guan C. Triblock copolymer synthesis of mesoporous silica in strong acid medium 1. Characterization of samples and effects of cosolvent and cosurfactant on morphology of mesoporous silica. Abstr Pap Am Chem Soc. 2003;226:U263-U264.
18. Pang XL, Tang FQ. Morphological control of mesoporous materials using inexpensive silica sources. Micropor Mesopor Mat. 2005;85: 1-6.
19. Langguth P, Kovacevic I, Parojcic J, Homsek I, Tubic-Grozdanis M. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. Mol Pharm. 2009;6:40-47.
20. Elqidra R, Unlu N, Capan Y, Sahin G, Dalkara T, Hincal AA. Effect of polymorphism on in vitro in vivo properties of carbamazepine conventional tablets. J Drug Deliv Sci Technol. 2004;14:147-153.
21. Grzesiak AL, Lang M, Kim K, Matzger AJ. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci. 2003;92:2260-2271.
22. Cai Q, Lin WY, Xiao FS, Pang WQ, Chen XH, Zou BS. The preparation of highly ordered MCM-41 with extremely low surfactant concentration. Micropor Mesopor Mat. 1999;32:1-15.
23. Vautier-Giongo C, Pastore HO. Micellization of CTAB in the presence of silicate anions and the exchange between bromide and silicate at the micelle surface: A step to understand the formation of mesoporous molecular sieves at extremely low surfactant and silicate concentrations. J Colloid Interface Sci. 2006;299:874-882.
24. Zana R, Frasch J, Soulard M, Lebeau B, Patarin J. Fluorescence probing investigations of the mechanism of formation of organized mesoporous silica. Langmuir. 1999;15:2603-2606.
25. He QJ, Zhang ZW, Gao Y, Shi JL, Li YP. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small. 2009;5:2722-2729.
26. Cejka J, Mintova S. Perspectives of micro/mesoporous composites in catalysis. Catal Rev. 2007;49:457-509.
27. Choy JH, Lee HC, Jung H, Kim H, Boo H. Exfoliation and restacking route to anatase-layered titanate nanohybrid with enhanced photocata-lytic activity. Chem Mater. 2002;14:2486-2491.
28. Zhao D, Feng J, Huo Q, et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science. 1998;279:548-552.
29. Liu K, Feng Q, Yang Y, Zhang G, Ou L, Lu Y. Preparation and characterization of amorphous silica nanowires from natural chrysotile. J Non-Cryst Solids. 2007;353:1534-1539.
30. Wang YD, Zhang S, Ma CL, Li HD. Synthesis and room temperature photoluminescence of ZnO/CTAB ordered layered nanocomposite with fake-like architecture. J Lumin. 2007;126:661-664.
31. Ding Y, Mathur A, Chen M, Erlebacher J. Epitaxial casting of nano-tubular mesoporous platinum. Angew Chem Int Ed Engl. 2005;44: 4002-4006.
32. Ji QM, Acharya S, Hill J P, et al. Hierarchic nanostructure for auto-modulation of material release: mesoporous nanocompartment flms. Adv Funct Mater. 2009;19:1792-1799.
33. Wang YM, Wu Z Y, Wang HJ, Zhu JH. Fabrication of metal oxides occluded in ordered mesoporous hosts via a solid-state grinding route: The infuence of host-guest interactions. Adv Funct Mater. 2006;16: 2374-2386.
34. Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm. 2009;73:373-384.
35. Nokhodchi A, Aliakbar R, Desai S, Javadzadeh Y. Liquisolid compacts: The effect of cosolvent and HPMC on theophylline release. Colloids Surf B Biointerfaces. 2010;79:262-269.
36. Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm. 2007;341:26-34.
37. Javadzadeh Y, Musaalrezaei L, Nokhodchi A. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Int J Pharm. 2008;362:102-108.
38. Javadzadeh Y, Shariati H, Movahhed-Danesh E, Nokhodchi A. Effect of some commercial grades of microcrystalline cellulose on fowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm. 2009;35:243-251.
39. Bravo SA, Lamas MC, Salamon CJ. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J Pharm Pharm Sci. 2002;5:213-219.
40. Builders PF, Bonaventure AM, Tiwalade A, Okpako LC, Attama AA. Novel multifunctional pharmaceutical excipients derived from micro-crystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending. Int J Pharm. 2010;388: 159-167.
41. Emami J. In vitro-in vivo correlation: From theory to applications. J Pharm Pharm Sci. 2006;9:169-189.